![SALUDA MEDICAL Evoke SCS System Скачать руководство пользователя страница 47](http://html.mh-extra.com/html/saluda-medical/evoke-scs-system/evoke-scs-system_user-manual_803641047.webp)
Evoke
®
SCS System User Manual
Table 15-10 Electromagnetic immunity - electrostatic discharge and mains power.
The Evoke SCS System is intended for use in the electromagnetic environment specified
below. The patient, doctor or any other user of the Evoke SCS System should ensure that
it is used in such an environment.
Immunity Test
IEC 60601 Test Level
Compliance Level
Electromagnetic
environment
–
guidance
Floors should be
wood, concrete, or
±2 kV, ±4 kV, ±6 kV,
ceramic tile. If floors
Electrostatic
± 8 kV contact
±8 kV contact
are covered with
discharge (ESD)
± 2 kV, ± 4 kV, ± 8 kV,
±2 kV, ±4 kV, ±8 kV,
synthetic material,
IEC 61000-4-2
± 15 kV air
±15 kV air
the relative humidity
should be at least
30%
Electrical fast
transient/burst
IEC 61000-4-4
± 2 kV gaseous
discharge at 100 kHz
repetition frequency
± 2 kV @100 kHz
repetition frequency
for power supply
lines to Charger
power adapter.
Mains power quality
should be that of a
typical household,
commercial or
hospital
environment. If the
user of the Charger
power adapter
requires continued
operation during
mains power
interruptions, it is
recommended that
the Charger power
adapter be powered
from an
uninterruptible
power supply or a
battery.
Surge Immunity
IEC 61000-4-5
± 0.5 kV, ± 1 kV
± 0.5 kV, ± 1 kV
power supply line to
Charger power
adapter.
Voltage dips,
short
interruptions and
voltage variations
on power supply
input lines
IEC 61000-4-11
Voltage Dips:
0% residual voltage
for 0.5 cycle at 0 °, 45
°, 90 °, 135 °, 180 °,
225 °, 270 °, 315 °;
0 % residual voltage;
1 cycle, and
70% residual voltage;
25/30 cycles
Single phase: at 0 °
Voltage
Interruptions:
Voltage Dips:
0% residual voltage
for 0.5 cycle at 0 °, 45
°, 90 °, 135 °, 180 °,
225 °, 270 °, 315 °;
0% residual voltage
for 1 cycle at 0 °;
70% residual voltage
for 25 cycles at 0 °;
Voltage
Interruptions:
0% residual voltage
for 250 cycles at 0 °;
CLIN-UMAN-005176
Revision: 4.01
Page 47 of 53